Overview
COYA market data
Price History
COYA price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for COYA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Coya Therapeutics To Present Overview Of Ongoing ALSTARS Trial At European Network To Cure ALS June 24-26Benzinga · Jun 18, 2026, 12:15 PM
Coya Therapeutics Initiates Blinded Extension Phase Of Its ALSTARS Trial; Patients Who Complete The 24-Week Placebo-Controlled, Double-Blind Phase Enter The Blinded Extension Phase Of The StudyBenzinga · Jun 8, 2026, 12:15 PM
This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For FridayBenzinga · Jun 5, 2026, 12:55 PM
8-K filing — Coya Therapeutics, Inc. (COYA)SEC EDGAR · May 12, 2026, 12:48 PM